Normal view MARC view ISBD view

Current status of nanotechnology in oncology

In Radiation Oncology
Contributor(s): Sharma L | Sharma G | Kaushal J | Gupta MC | Sharma V | | Sharma S.
Material type: materialTypeLabelArticleSeries: Vol 9 Issues 2.Publisher: 2009Description: 98-103.Subject(s): DDC classification: In: Radiation OncologySummary: Nanotechnology is the development of engineered device at the atomic, molecular and macromolecular level in nanometer range. One nanometer is equal to one-billionth of a meter which is approximately the width of 5 atoms. Nanotechnology is considered as a technology of the future which is presently making a significant impact in treating various malignancies. Different noan-particle platforms can be; drug-encapsulated liposomes, polymer-drug conjugates, nano-emulsions, dendrimers, micelles, nano-shells, engineered viral nanoparticles, albumin-based nano-particles, polysaccharide-based-nano-particles, metallic nano-particles and ceramic nano-particles. Twenty four nanotechnology based therapeutic products have been approved for more than 80% of the total amount. Liposomes are spherical lipid vesicles with a bilayered membrane structure which have been widely used as parmaceutical carries and can be coated with polymers such as PEG (poly ethylene glycol). PEG is a polymer-drug conjugate which prolongs dr
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
Articles Articles Tata Memorial Hospital
(Browse shelf) Available AR9806

Nanotechnology is the development of engineered device at the atomic, molecular and macromolecular level in nanometer range. One nanometer is equal to one-billionth of a meter which is approximately the width of 5 atoms. Nanotechnology is considered as a technology of the future which is presently making a significant impact in treating various malignancies. Different noan-particle platforms can be; drug-encapsulated liposomes, polymer-drug conjugates, nano-emulsions, dendrimers, micelles, nano-shells, engineered viral nanoparticles, albumin-based nano-particles, polysaccharide-based-nano-particles, metallic nano-particles and ceramic nano-particles. Twenty four nanotechnology based therapeutic products have been approved for more than 80% of the total amount. Liposomes are spherical lipid vesicles with a bilayered membrane structure which have been widely used as parmaceutical carries and can be coated with polymers such as PEG (poly ethylene glycol). PEG is a polymer-drug conjugate which prolongs dr

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha